The START Center for Cancer Research Revenue and Competitors

Location

#1356

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • The START Center for Cancer Research's estimated annual revenue is currently $24.8M per year.(i)
  • The START Center for Cancer Research's estimated revenue per employee is $189,313

Employee Data

  • The START Center for Cancer Research has 131 Employees.(i)
  • The START Center for Cancer Research grew their employee count by 236% last year.

The START Center for Cancer Research's People

NameTitleEmail/Phone
1
Global Chief HR OfficerReveal Email/Phone
2
Chief Growth OfficerReveal Email/Phone
3
Global Chief Medical OfficerReveal Email/Phone
4
Chief Development Officer (CDO)Reveal Email/Phone
5
General Counsel, Chief Legal Officer, & Corporate SecretaryReveal Email/Phone
6
Chief Compliance OfficerReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
SVP SalesReveal Email/Phone
9
VP Human ResourcesReveal Email/Phone
10
VP ComplianceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.5M1645%N/AN/A
#2
$13.8M89-7%N/AN/A
#3
$18.6M1203%$1.8MN/A
#4
$0.9M6-40%N/AN/A
#5
$4.2M270%N/AN/A
#6
$3.4M2247%N/AN/A
#7
$9.6M6229%N/AN/A
#8
$0.9M620%N/AN/A
#9
$1.7M1110%N/AN/A
#10
$15.2M98-8%N/AN/A
Add Company

What Is The START Center for Cancer Research?

Deeply rooted in community oncology centers globally, the START Center for Cancer Research (\START\) provides patients with access to specialized Phase 1 clinical trials for novel anti-cancer agents. With research sites in the United States and in Spain, Portugal, and Ireland, START’s clinical trial sites have conducted more than 1,300 early phase clinical trials, including for 45 therapies that have gained FDA/EMA approval. Founded in Texas in 2007, START today boasts 25 Principal Investigators (PIs) across its worldwide clinical trial sites. With over 100,000+ square feet of world-class research facilities, START offers patients comprehensive treatment plans that include multi-specialty services, genetic profiling of tumors, targeted therapies, state-of-the-art treatment technology, and advanced access to clinical research options. START is committed to accelerating passage from trials to treatments, and to delivering hope to patients, families, and physicians around the world.

keywords:N/A

N/A

Total Funding

131

Number of Employees

$24.8M

Revenue (est)

236%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.8M1317%N/A
#2
$27.5M13116%N/A
#3
$28.8M13119%N/A
#4
$21M13126%N/A
#5
$3.5M13243%N/A